SeaStar Medical Holding (ICU) Cash from Operations (2021 - 2026)
SeaStar Medical Holding's (ICU) quarterly Cash from Operations came in at 2761000.0 in Q1 2026, down 4.03% YoY from 2876990.18 in Q1 2025, and up 32.56% on a QoQ basis from 4094000.0 in Q4 2025.
SeaStar Medical Holding (ICU) Cash from Operations (2021 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 6 years of Cash from Operations data on file, last reported at 2761000.0 in Q1 2026.
- Quarterly Cash from Operations fell 4.03% year-over-year to 2761000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 13706000.0 (up 9.67% YoY) and the FY2025 annual result came in at 13599000.0, up 15.04% from the prior year.
- Cash from Operations advanced to 2761000.0 in Q1 2026, from 4094000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 587000.0 in Q1 2022 to a low of 5302000.0 in Q4 2022.
- A 5-year average of 2967411.76 and a median of 2824000.0 in 2024 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations sank 2437.58% — and 2025, when it rose 23.91%.
- Tracing ICU's Cash from Operations over 5 years: stood at 5302000.0 in 2022, then advanced by 15.41% to 4485000.0 in 2023, then slipped by 4.64% to 4693000.0 in 2024, then grew by 12.76% to 4094000.0 in 2025, then soared by 32.56% to 2761000.0 in 2026.
- The last three Cash from Operations figures came in at 2761000.0 (Q1 2026), 4094000.0 (Q4 2025), and 3844000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | SeaStar Medical Holding | 13.68 Mn | 6.68 Mn | 561,000.00 | -2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.99 Mn |
| Jun 30, 2026 | -2.99 Mn |
| Mar 31, 2026 | -2.76 Mn |
| Mar 31, 2026 | -2.76 Mn |
| Dec 31, 2025 | -4.09 Mn |
| Dec 31, 2025 | -4.09 Mn |
| Sep 30, 2025 | -3.84 Mn |
| Sep 30, 2025 | -3.84 Mn |
| Jun 30, 2025 | -3.01 Mn |
| Jun 30, 2025 | -3.01 Mn |
| Mar 31, 2025 | -2.65 Mn |
| Mar 31, 2025 | -2.65 Mn |
| Dec 31, 2024 | -4.69 Mn |
| Dec 31, 2024 | -4.69 Mn |
| Sep 30, 2024 | -5.00 Mn |
| Sep 30, 2024 | -5.00 Mn |
| Jun 30, 2024 | -2.82 Mn |
| Jun 30, 2024 | -2.82 Mn |
| Mar 31, 2024 | -3.49 Mn |
| Mar 31, 2024 | -3.49 Mn |